BioCatalystWatch
STOKWorkspace / STOK / OverviewCompany library
Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc. (STOK)

Website

Price
Market cap
Next catalystExpected 1H 2027STK-002 — OSPREY · Phase 1 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

zorevunersen

SCN1A

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

STK-002

OPA1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

SYNGAP1

SYNGAP1

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

STK-002

OPA1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

zorevunersen

SCN1A

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

SYNGAP1

SYNGAP1

PreINDP1P2P3FilingApproved

Other pipelines

ASO-14

OPA1 pre-mRNA

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

STOK PR & News

PR & News

STOK SEC archive